226 related articles for article (PubMed ID: 24449506)
1. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.
Liang JW; Zhang JJ; Zhang T; Zheng ZC
Tumour Biol; 2014 May; 35(5):4849-58. PubMed ID: 24449506
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis.
Wang HB; Liao XF; Zhang J
Medicine (Baltimore); 2017 Nov; 96(44):e8437. PubMed ID: 29095284
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
5. HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
Cao GD; Chen K; Xiong MM; Chen B
PLoS One; 2016; 11(8):e0161219. PubMed ID: 27536774
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis.
Li X; Zhao H; Gu J; Zheng L
World J Surg Oncol; 2016 Feb; 14(1):38. PubMed ID: 26897036
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification].
Li Y; Xue XW; Luo YF; Wu HW; Chen J; Zhou WX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):486-491. PubMed ID: 29996311
[No Abstract] [Full Text] [Related]
10. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
[TBL] [Abstract][Full Text] [Related]
11. IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status.
Damasceno EA; Carneiro FP; Magalhães AV; Carneiro Mde V; Takano GH; Vianna LM; Seidler HB; Castro TM; Muniz-Junqueira MI; Amorim RF; Ferreira VM; Motoyama AB
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2163-8. PubMed ID: 25323937
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.
Xu J; Zhu R; Fan L; Ge S; Wei W; Li X; Da L; Jia Z; Zhao Z; Ning J; Da J; Peng W; Gu K; Sun G
BMC Cancer; 2019 Jul; 19(1):650. PubMed ID: 31266459
[TBL] [Abstract][Full Text] [Related]
13. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
[TBL] [Abstract][Full Text] [Related]
15. HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer.
Han S; Park S; An J; Yang JY; Chung JW; Kim YJ; Kim KO; Park DK; Kwon KA; Lee WK; Nam S; Kim JH
Sci Rep; 2020 Mar; 10(1):5270. PubMed ID: 32210254
[TBL] [Abstract][Full Text] [Related]
16. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a meta-analysis of observational studies.
Li Y; Du P; Zhou Y; Cheng Q; Chen D; Wang D; Sun T; Zhou J; Patel R
J Surg Res; 2014 Oct; 191(2):413-22. PubMed ID: 25060322
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis.
Du J; Shen Y; Yan W; Wang J
World J Surg Oncol; 2020 Sep; 18(1):233. PubMed ID: 32873315
[TBL] [Abstract][Full Text] [Related]
18. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of p53 expression in gastric cancer: a meta-analysis.
Wei K; Jiang L; Wei Y; Wang Y; Qian X; Dai Q; Guan Q
J Cancer Res Clin Oncol; 2015 Apr; 141(4):735-48. PubMed ID: 25316440
[TBL] [Abstract][Full Text] [Related]
20. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
Cao GD; Chen K; Chen B; Xiong MM
BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
